Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.33.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.33.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XDNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.493NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.493NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.351.2 (Beta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.351.2 (Beta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.640.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.640.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBF.7.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBF.7.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FY.5.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.5.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FP.2.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FP.2.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.2.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.2.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JW.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JW.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.43NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.43NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.85NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.85NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.66 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.66 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.72 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.72 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.133 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.133 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.5.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.5.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.168NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.168NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.39NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.39NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.57NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.57NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AH.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AH.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.289NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.289NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.365NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.365NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.21NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used